id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2011-0931-0032,EPA,EPA-HQ-OPP-2011-0931,5/29/12.  Benfluralin Final Work Plan,Supporting & Related Material,Work Plan,2012-06-08T04:00:00Z,2012,6,,,2012-06-08T19:43:13Z,,0,0,090000648102328e
EPA-HQ-OPP-2011-0931-0033,EPA,EPA-HQ-OPP-2011-0931,"5/10/12. Benfluralin: Response to comments on Registration Review Docket (EPA-HQ-OPP-2011-0931) on the need for inhalation, neurotoxicity battery (acute and subchronic), carcinogenicity, and immunotoxicity studies.",Supporting & Related Material,Comment Response,2012-06-08T04:00:00Z,2012,6,,,2012-06-08T19:43:21Z,,0,0,090000648103a47d
EPA-HQ-OPP-2011-0931-0034,EPA,EPA-HQ-OPP-2011-0931,5/15/12. The Environmental Fate and Effects Division Response to Comments Posted to the Registration Review Docket for Benfluralin; Docket ID EPA-HQ-OPP-2011-0931,Supporting & Related Material,Comment Response,2012-06-08T04:00:00Z,2012,6,,,2012-06-08T19:43:29Z,,0,0,090000648103a47e